Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 24, 2010

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Bepreve	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vivitrol	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Colcrys	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Sabril	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Twynsta	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Apriso	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Besivance	New Drug Appeal	Require Prior Approval	Prior Approval Required
Ranexa	New Drug Appeal	Require Prior Approval	Prior Approval Required
Vimpat	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Lamictal XR	New Drug Appeal	Removed from Agenda Prior to Mtg	Prior Approval Required
Ulesfia	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Zenpep	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Xibrom	PDL Appeal	Require Prior Approval	Prior Approval Required
Istalol	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer